IBIO iBio, Inc.

iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.

$0.66  -0.07 (-9.10%)
As of 12/03/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/04/2011
Outstanding shares:  217,957,594
Average volume:  5,469,991
Market cap:   $159,087,248
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    451033203
ISIN:        US4510332038
Sedol:      BG43QY2
Valuation   (See tab for details)
PE ratio:   -5.81
PB ratio:   1.44
PS ratio:   73.24
Return on equity:   -24.48%
Net income %:   -1,133.20%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy